1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: New biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Collins LG, Haines C, Perkel R and Enck
RE: Lung cancer: Diagnosis and management. Am Fam Physician.
75:56–63. 2007.PubMed/NCBI
|
5
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H
and Zou X: Report of cancer incidence and mortality in China, 2010.
Ann Transl Med. 2:612014.PubMed/NCBI
|
6
|
Kutikhin AG, Yuzhalin AE, Brailovskiy VV,
Zhivotovskiy AS, Magarill YA and Brusina EB: Analysis of cancer
incidence and mortality in the industrial region of South-East
Siberia from 1991 through 2010. Asian Pac J Cancer Prev.
13:5189–5193. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bradbury P, Sivajohanathan D, Chan A,
Kulkarni S, Ung Y and Ellis PM: Postoperative adjuvant systemic
therapy in completely resected non-small-cell lung cancer: A
systematic review. Clin Lung Cancer. 18:259–273.e258. 2017.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Sandler A, Gray R, Perry MC, Brahmer J,
Schiller JH, Dowlati A, Lilenbaum R and Johnson DH:
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell
lung cancer. N Engl J Med. 355:2542–2550. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Steeg PS: Metastasis suppressors alter the
signal transduction of cancer cells. Nat Rev Cancer. 3:55–63. 2003.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Hydbring P and Badalian-Very G: Clinical
applications of microRNAs. F1000Res. 2:1362013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Castro D, Moreira M, Gouveia AM, Pozza DH
and De Mello RA: MicroRNAs in lung cancer. Oncotarget.
8:81679–81685. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yang CL, Zheng XL, Ye K, Ge H, Sun YN, Lu
YF and Fan QX: MicroRNA-183 acts as a tumor suppressor in human
non-small cell lung cancer by down-regulating MTA1. Cell Physiol
Biochem. 46:93–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yao Y, Shen H, Zhou Y, Yang Z and Hu T:
MicroRNA-215 suppresses the proliferation, migration and invasion
of non-small cell lung carcinoma cells through the downregulation
of matrix metalloproteinase-16 expression. Exp Ther Med.
15:3239–3246. 2018.PubMed/NCBI
|
16
|
Liu J, Jia Y, Jia L, Li T, Yang L and
Zhang G: MicroRNA-615-3p inhibits the tumor growth and metastasis
of NSCLC via inhibiting IGF2. Oncol Res. Mar 21–2018.(Epub ahead of
print). doi: 10.3727/096504018X15215019227688.
|
17
|
Li G, Wu F, Yang H, Deng X and Yuan Y:
MiR-9-5p promotes cell growth and metastasis in non-small cell lung
cancer through the repression of TGFBR2. Biomed Pharmacother.
96:1170–1178. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wei K, Pan C, Yao G, Liu B, Ma T, Xia Y,
Jiang W, Chen L and Chen Y: MiR-106b-5p promotes proliferation and
inhibits apoptosis by regulating BTG3 in non-small cell lung
cancer. Cell Physiol Biochem. 44:1545–1558. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang J, Lu Y, Ding H, Gu T, Gong C, Sun J,
Zhang Z, Zhao Y and Ma C: The miR-875-5p inhibits SATB2 to promote
the invasion of lung cancer cells. Gene. 644:13–19. 2018.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Li S, Gao M, Li Z, Song L, Gao X, Han J,
Wang F, Chen Y, Li W, Yang J and Han X: Role of microRNAs in
metastasis of non-small cell lung cancer. Front Biosci (Landmark
Ed). 21:998–1005. 2016. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Yin C, Mou Q, Pan X, Zhang G, Li H and Sun
Y: MiR-577 suppresses epithelial-mesenchymal transition and
metastasis of breast cancer by targeting Rab25. Thorac Cancer.
9:472–479. 2018. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang LY, Li B, Jiang HH, Zhuang LW and Liu
Y: Inhibition effect of miR-577 on hepatocellular carcinoma cell
growth via targeting beta-catenin. Asian Pac J Trop Med. 8:923–929.
2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Jiang H, Ju H, Zhang L, Lu H and Jie K:
microRNA-577 suppresses tumor growth and enhances chemosensitivity
in colorectal cancer. J Biochem Mol Toxicol. 31:2017. View Article : Google Scholar :
|
24
|
Xue KC, Hu DD, Zhao L, Li N and Shen HY:
MiR-577 inhibits papillary thyroid carcinoma cell proliferation,
migration and invasion by targeting SphK2. Eur Rev Med Pharmacol
Sci. 21:3794–3800. 2017.PubMed/NCBI
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhan B, Lu D, Luo P and Wang B: Prognostic
value of expression of MicroRNAs in non-small cell lung cancer: A
systematic review and meta-analysis. Clin Lab. 62:2203–2211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Matikas A, Syrigos KN and Agelaki S:
Circulating biomarkers in non-small-cell lung cancer: Current
status and future challenges. Clin Lung Cancer. 17:507–516. 2016.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Ansari J, Shackelford RE and El-Ost H:
Epigenetics in non-small cell lung cancer: From basics to
therapeutics. Transl Lung Cancer Res. 5:155–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ding X, Zhong T, Jiang L, Huang J, Xia Y
and Hu R: miR-25 enhances cell migration and invasion in
non-small-cell lung cancer cells via ERK signaling pathway by
inhibiting KLF4. Mol Med Rep. 17:7005–7016. 2018.PubMed/NCBI
|
30
|
Zhang W, Shen C, Li C, Yang G, Liu H, Chen
X, Zhu D, Zou H, Zhen Y, Zhang D and Zhao S: miR-577 inhibits
glioblastoma tumor growth via the Wnt signaling pathway. Mol
Carcinog. 55:575–585. 2016. View
Article : Google Scholar : PubMed/NCBI
|
31
|
Yu Z, Zhang W and Deng F: MicroRNA-577
inhibits gastric cancer growth by targeting E2F transcription
factor 3. Oncol Lett. 10:1447–1452. 2015.PubMed/NCBI
|
32
|
Yuan X, He J, Sun F and Gu J: Effects and
interactions of MiR-577 and TSGA10 in regulating esophageal
squamous cell carcinoma. Int J Clin Exp Pathol. 6:2651–2667.
2013.PubMed/NCBI
|
33
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Grier DG, Thompson A, Kwasniewska A,
McGonigle GJ, Halliday HL and Lappin TR: The pathophysiology of HOX
genes and their role in cancer. J Pathol. 205:154–171. 2005.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Kusakabe M, Kutomi T, Watanabe K, Emoto N,
Aki N, Kage H, Hamano E, Kitagawa H, Nagase T, Sano A, et al:
Identification of G0S2 as a gene frequently methylated in squamous
lung cancer by combination of in silico and experimental
approaches. Int J Cancer. 126:1895–1902. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zhang Y, Li XJ, He RQ, Wang X, Zhang TT,
Qin Y, Zhang R, Deng Y, Wang HL, Luo DZ and Chen G: Upregulation of
HOXA1 promotes tumorigenesis and development of nonsmall cell lung
cancer: A comprehensive investigation based on reverse
transcription-quantitative polymerase chain reaction and
bioinformatics analysis. Int J Oncol. 53:73–86. 2018.PubMed/NCBI
|
37
|
Zhan M, Qu Q, Wang G, Liu YZ, Tan SL, Lou
XY, Yu J and Zhou HH: Let-7c inhibits NSCLC cell proliferation by
targeting HOXA1. Asian Pac J Cancer Prev. 14:387–392. 2013.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Tian X, Ma J, Wang T, Tian J, Zhang Y, Mao
L, Xu H and Wang S: Long non-coding RNA HOXA transcript antisense
RNA myeloid-specific 1-HOXA1 axis downregulates the
immunosuppressive activity of myeloid-derived suppressor cells in
lung cancer. Front Immunol. 9:4732018. View Article : Google Scholar : PubMed/NCBI
|